Top Markets
Coin of the day
Arecor Therapeutics plc Arecor Therapeutics plc

Arecor Therapeutics plc

AREC
Rang in Aktien #39891
Arecor Therapeutics PLC is a biopharmaceutical enterprise dedicated to creating... Arecor Therapeutics PLC is a biopharmaceutical enterprise dedicated to creating therapies for diabetes and various other medical conditions. The company utilizes its exclusive Arestat formulation technology platform to both cultivate its own range of specialized products (for diabetes and other ailments) and collaborate with pharmaceutical and biotechnology partners to refine and enhance existing therapeutic formulations. Its pipeline includes AT247, an exceptionally fast-acting insulin aimed at individuals with Type I and Type II diabetes, and AT278, a highly concentrated rapid-acting insulin formulation engineered to hasten insulin absorption following injection. Established in 2007, the company's main office is situated in Little Chesterford, United Kingdom.
Aktienkurs
$0.80961743
Zuletzt synchronisiert: 2026-08-13
Marktkapitalisierung
$305.68K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-5.76%
Land
GB
Handel Arecor Therapeutics plc (AREC)

Kategorie

Kursverlauf für Arecor Therapeutics plc (AREC)
Höchster Schlusskurs: $0.80 am 2026-08-01

Niedrigster Schlusskurs: $3.36 am 2021-06-01
Kursverlauf der Aktie von Arecor Therapeutics plc von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -8.47%
2025 13.98%
2024 -60.84%
2023 -21.41%
2022 -43.24%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$517.18 32.51%
US
$857.76 31.47%
NL
$744.96 9.07%
CH
$1.07K -6.40%
KR
$259.89 14.81%
BE